Authors:
Wallace, DJ
Linker-Israeli, M
Hallegua, D
Silverman, S
Silver, D
Weisman, MH
Citation: Dj. Wallace et al., Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis andpilot study, RHEUMATOLOG, 40(7), 2001, pp. 743-749
Authors:
Nicassio, PM
Weisman, MH
Schuman, C
Young, CW
Citation: Pm. Nicassio et al., The role of generalized pain and pain behavior in tender point scores in fibromyalgia, J RHEUMATOL, 27(4), 2000, pp. 1056-1062
Authors:
Furst, DE
Breedveld, FC
Burmester, GR
Crofford, JJ
Emery, P
Feldmann, M
Kalden, JR
Kavanaugh, AF
Keystone, EC
Klareskog, LG
Lipsky, PE
Maini, RN
Russell, AS
Scott, DL
Smolen, JS
Van de Putte, LBA
Visher, TL
Weisman, MH
Citation: De. Furst et al., Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000), ANN RHEUM D, 59, 2000, pp. 1-2
Citation: Mh. Weisman et Js. Smolen, Future trends in the management of rheumatoid arthritis - (Based on the International Rheumatology Round Tables held March 27-28, 1998 and February 19-20, 1999) - Introduction, RHEUMATOLOG, 38, 1999, pp. 1-2
Authors:
Clements, PJ
Furst, DE
Wong, WK
Mayes, M
White, B
Wigley, F
Weisman, MH
Barr, W
Moreland, LW
Medsger, TA
Steen, V
Martin, RW
Collier, D
Weinstein, A
Lally, E
Varga, J
Weiner, S
Andrews, B
Abeles, M
Seibold, JR
Citation: Pj. Clements et al., High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis - Analysis of a two-year, double-blind, randomized, controlled clinicaltrial, ARTH RHEUM, 42(6), 1999, pp. 1194-1203
Authors:
Felson, DT
LaValley, MP
Baldassare, AR
Block, JA
Caldwell, JR
Cannon, GW
Deal, C
Evans, S
Fleischmann, R
Gendreau, RM
Harris, ER
Matteson, EL
Roth, SH
Schumacher, HR
Weisman, MH
Furst, DE
Citation: Dt. Felson et al., The Prosorba column for treatment of refractory rheumatoid arthritis - A randomized, double-blind, sham-controlled trial, ARTH RHEUM, 42(10), 1999, pp. 2153-2159